Pre-therapeutic lymphocytopenia: a new prognostic factor for failure of endovesical BCG-immunotherapy in non-muscle invasive bladder cancer

Pre-therapeutic lymphocytopenia: a new prognostic factor for failure of endovesical BCG-immunotherapy in non-muscle invasive bladder cancer

Abstract Background Inflammation plays a key role in the initiation and development of cancers. The prognostic value of inflammation biomarkers is proven in several urological and non-urological cancers. Knowing that the mechanism of action of endovesical BCG-immunotherapy in the treatment of non-mu...

Full description

Bibliographic Details
Main Authors: Idriss Ziani, Ahmed Ibrahimi, Omar Bellouki, Hachem Elsayegh, Redouane Abouqal, Yassine Nouini, Amal Bouziane
Format: Article
Language:English
Published: SpringerOpen 2023-03-01
Series:African Journal of Urology
Subjects:
Lymphocytopenia
BCG-immunotherapy
Recurrence
Progression
Online Access:https://doi.org/10.1186/s12301-023-00348-4

Internet

https://doi.org/10.1186/s12301-023-00348-4

Similar Items